首页> 外文期刊>Expert review of pharmacoeconomics & outcomes research >Ethical, legal and social implications of rare diseases and orphan drugs in Europe: Meeting report of a Brocher symposium
【24h】

Ethical, legal and social implications of rare diseases and orphan drugs in Europe: Meeting report of a Brocher symposium

机译:欧洲稀有疾病和孤儿药的伦理,法律和社会影响:Brocher研讨会的会议报告

获取原文
获取原文并翻译 | 示例
           

摘要

Ethical, legal and social implications of rare diseases and orphan drugs in Europe (Brocher symposium) Geneva, Switzerland 18-19 April 2013 As part of the Scientific Program of the Fondation Brocher, a two-day symposium on orphan drugs and rare diseases was held on the shores of Lac Léman in Geneva. Specific focus was on the ethical, legal and social implications of rare diseases and orphan drugs in Europe. The symposium gathered about 30 international stakeholders and experts, representing different scientific disciplines, the pharmaceutical industry and patient representatives.
机译:欧洲稀有疾病和孤儿药的伦理,法律和社会影响(布鲁彻研讨会)瑞士日内瓦2013年4月18日至19日,作为布鲁彻基金会科学计划的一部分,举行了为期两天的孤儿药物和稀有疾病研讨会在日内瓦LacLéman海岸上。特别关注欧洲罕见病和孤儿药的伦理,法律和社会影响。座谈会聚集了约30位国际利益相关者和专家,代表不同的科学学科,制药行业和患者代表。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号